Pharmaceutical Executive September 27, 2021
Pharmaceutical Executive Editorial Staff

Americans 18-24 years old are one of the country’s most hesitant vaccine-eligible populations. In July, according to the CDC, only 42% of them had been fully vaccinated for COVID-19. How do pharma companies and governments walk the line of making it cool to get a vaccine? Might influencers be enough to sway people on a polarized medical issue? While PRECISIONeffect’s Associate Creative Director Isaac Simpson thinks the outlook is mixed, there is potential. We spoke with him to ask what he sees happening with Gen Z and potential efforts to date to get them on board.

Pharm Exec: How can influencers have an impact on the 18-24 year old group?

Isaac Simpson: That state and federal governments are promoting COVID...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Healthcare System, Interview / Q&A, Pharma, Pharma / Biotech, Public Health / COVID, Trends
How Will Walgreens’ Expansion into Specialty Pharmacy Affect the Industry?
STAT+: After AI protein folding, David Baker’s lab identifies millions of smaller drug candidates
Fierce Biotech Layoff Tracker 2024: BMS to cut 2K+ roles; Tessera trims workforce in shift to clinic
What Do Weight-Loss Drugs Mean for Diet Industry Built on Eating Less and Exercise?
Podcast #1: Doing Digital Deals in Life Sciences | Corporate Culture

Share This Article